April 29th, 2015 | The Motley Fool by Beth McKenna
Philadelphia-based start-up BioBots is aiming to shake up the human tissue engineering — or “3D bioprinting” — space by making its desktop 3D bioprinters available for only $5,000 to scientists, engineers, and medical professionals who qualify for its beta testing program.
This low-cost product strategy aims at putting bioprinters into the hands of as many professionals in the biotech and medical fields as possible. It has the potential to unleash a wave of innovation in the biotech world, and possibly catapult this upstart into the bigger leagues.
BioBots: Aiming to democratize the bioprinting world
BioBots was founded by several recent graduates of the University of Pennsylvania. Among a field of 48 finalists, whittled down from more than 500 entrants, the upstart from “Rocky’s” hometown knocked out the competition for “Most Innovative” honors at Oracle Corp.‘s South by Southwest 2015 Accelerator venture competition last month. SXSW has a reputation as a breeding ground for innovative new ideas in the tech realm.
DreamIt Health Philadelphia 2015, running June 26th thru Oct 16th, is looking for startup teams who are fanatical about solving significant healthcare problems by combining relentless business execution, software or hardware, and inspired design.
- seed capital (up to $300k per team)
- access (customers, partners, investors, KOLs, SMEs)
- coaching (from been-there-before, successful entrepreneurs)
- freebies (legal, accounting, space, AWS, etc)
- tools/techniques/best practices
The program is an unrivaled opportunity to work closely with Penn Medicine and Independence Blue Cross who have committed to provide access to and partnership with clinicians, executives, and industry leaders for designing, testing, launching, and deploying your solution at scale. Teams also benefit from speakers, office hours and content designed around healthcare-specific challenges such as navigating regulatory and reimbursement hurdles.
DreamIt Health alumni include Biomeme, Tissue Analytics, BioBots, and Haystack.
More info and applications at www.dreamithealth.com. Applications are due May 1st!
About DreamIt Ventures
We uniquely combine a startup accelerator program and an early-stage seed fund to help exceptional entrepreneurs build thriving, fundable companies. Our managing directors all have deep startup operating experience that we bring to bear in stacking the deck in favor of our portfolio companies. We’ve worked with 195 startups across all sectors and which today are valued at nearly a billion dollars. Over the course of a given DreamIt accelerator, participating teams identify and eliminate risks, build out their products, focus on customer acquisition and establish paths to building sustainable revenues. Beyond the program, DreamIt Ventures remains an active and committed investor in our alums helping wherever we can over the entire lifecycle of their companies.
April 1, 1015 | Technical.ly Philly by Juliana Reyes
At the beginning of 2012, a Philly media company opened its doors to three startups.
It was an experiment: Could the legacy media company behind the Philadelphia Inquirer, Daily News and Philly.com invigorate the tech scene while also modernizing its own offerings? (The following year, the New York Times launcheda similar program.)
Four years later, Project Liberty, as its known, is in the middle of its sixth class of startups (they have yet to be announced). The program was initially funded for three cycles by a $250,000 Knight Foundation grant, which got renewed for $345,000 in the summer of 2013.
So, has the experiment succeeded? That remains to be seen, but here’s what we do know: those first three Project Liberty startups had a big winter, full of exits and fundraising. And at least two of them have had an impact on the region’s tech scene.
The startups — SnipSnap, CloudMine and Versa — all joined Project Liberty fresh off completing DreamIt Ventures. (The DreamIt accelerator provided mentorship to the first three classes of Project Liberty and now, it supports the program “in any way that [it] can,” said DreamIt cofounder Steve Welch.)
- Center City couponing app SnipSnap was acquired by Toronto’s Slyce for $6.5 million. SnipSnap’s five employees are remaining in Philadelphia.
- Center City mobile back-end CloudMine raised $5 million in a Series A led by local investorSafeguard Scientifics. CloudMine employs 16 and is currently hiring.
- Sponsored content startup Versa, formerly known as ElectNext, was acquired by online petition site Change.org for an undisclosed amount. At the time of the acquisition, Versa no longer had a Philly presence. Its three staffers, including CEO Keya Dannenbaum, are joining Change.org.